Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models

SIMPLE SUMMARY: The objective of this study is to identify potential proteomic biomarkers in triple negative breast cancer (TNBC) that associate with response to PI3K inhibitors which are in clinical trials. We tested a panel of TNBC patient-derived xenograft (PDX) models for their tumor growth resp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Guo, Zhanfang, Primeau, Tina, Luo, Jingqin, Zhang, Cynthia, Sun, Hua, Hoog, Jeremy, Gao, Feng, Huang, Shixia, Edwards, Dean P., Davies, Sherri R., Aft, Rebecca, Ding, Li, Ellis, Matthew J., Li, Shunqiang, Ma, Cynthia X.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765949/
https://ncbi.nlm.nih.gov/pubmed/33371187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123857
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars